Capacity Building Assistance To Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for High-Risk Racial/Ethnic Minority Subpopulations, 19082-19090 [05-7286]
Download as PDF
19082
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
based organizations (CBOs), local and
state health departments, and other
public and private sector organizations
involved in health promotion and
disease prevention activities. The
Catalog of Federal Domestic Assistance
number for this program is 93.939.
B. Eligible Applicant
Assistance will be provided only to
the United States Conference of Mayors
(USCM). No other applications are
solicited.
The proposed program is in alignment
with the USCM mission, and the
organization’s mission facilitates the
successful and expedited
implementation of the program
proposed under this announcement.
The USCM is the official nonpartisan
organization of the nation’s 1,183 U.S.
cities with populations of 30,000 or
more. Each city is represented in the
Conference by its chief elected official,
the mayor. The primary roles of the
Conference of Mayors are to: (1)
Promote the development of effective
national urban/suburban policy; (2)
Strengthen federal-city relationships; (3)
Ensure that federal policy meets urban
needs; (4) Provide mayors with
leadership and management tools; and
(5) Create a forum in which mayors can
share ideas and information. The USCM
has 30 key programs, which include a
HIV/AIDS program. The Conference was
one of the first national organizations to
respond to the HIV/AIDS epidemic and
has worked closely with the CDC by
offering prevention grants, prevention
publications, and technical assistance.
Market research findings indicate that
the USCM is the only umbrella
organization exclusively for all mayors
nationwide. USCM has the access to,
and long-standing relationships with,
the mayors, and the infrastructure to
successfully conduct the proposed
program activities. The organization’s
existing relationships and access to
mayors facilitate immediate
implementation of program activities
because the organization does not have
to establish contacts and develop
relationships with the Mayors. In
addition, through its affiliate, The U.S.
Conference of Local Health Officials,
with a membership comprised of
approximately 2,000 local health
officials, the USCM has established
networks with local health officials. The
USCM was created specifically to
represent this wide variety of local
organizations and community officials
to the Federal government and other
national organizations, and is unique in
its role as a liaison between these
officials. The organization has served as
a policy-development and capacity-
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
building organization in
intergovernmental affairs for more than
65 years and has, as one of its major
objectives, the sharing of information
between local governments and federal
agencies.
The USCM is currently funded under
RFA 00054, entitled, ‘‘Information
Interchange and Technical and
Financial Assistance for HIV
Prevention.’’
C. Funding
Approximately $1,300,000 is available
in FY 2005 to fund this award. It is
expected that the award will begin on or
before June 1, 2005, and will be made
for a 12-month budget period within a
project period of up to four years.
Funding estimates may change.
D. Where To Obtain Additional
Information
For general comments or questions
about this announcement, contact:
Technical Information Management,
CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA
30341–4146, Telephone: 770–488–2700.
For program technical assistance,
contact:
Qairo Ali, Project Officer, 1600 Clifton
Road, NE., Mailstop E–35, Atlanta,
Georgia 30333, Telephone: 404–639–
5224, e-mail: cda1@cdc.gov.
For financial, grants management, or
budget assistance, contact: Roslyn
Curington, Grants Management
Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta,
GA 30341, Telephone: 770–488–2767, email: zlp8@cdc.gov.
Dated: April 6, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–7281 Filed 4–11–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Capacity Building Assistance To
Improve the Delivery and Effectiveness
of Human Immunodeficiency Virus
(HIV) Prevention Interventions for
High-Risk Racial/Ethnic Minority
Subpopulations
Announcement Type: New.
Funding Opportunity Number: RFA
05051.
Catalog of Federal Domestic
Assistance Number: 93.939.
Application Deadline: May 27, 2005.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
I. Funding Opportunity Description
Authority: This program is authorized
under Sections 301(a) and 317(k)(2) of
the Public Health Service Act, 42 U.S.C.
Sections 241 and 247b(k)(2).
Purpose: The purpose of this
announcement is to provide financial
assistance to non-governmental HIV
prevention organizations to provide
capacity building assistance (CBA),
including training and technical
assistance (TA), to adapt, tailor and
implement science-based, behavioral
HIV prevention interventions
specifically targeting high-risk racial/
ethnic minority subpopulations as
demonstrated by high-prevalence
epidemiological evidence and other
concrete quantitative and qualitative
data. The minority subpopulations are
migrant workers, transgender
individuals, and youth in non-school
settings, including lesbian/gay/bisexual/
transgender and questioning (LGBTQ)
youth.
The term ‘‘capacity building
assistance’’ or ‘‘CBA’’ means the
provision of information, TA, training,
and technology transfer for individuals
and organizations to improve the
delivery and effectiveness of HIV
prevention services. CBA does not
include the delivery of direct client HIV
prevention services and interventions.
CBA provided must be consistent
with the Centers for Disease Control and
Prevention’s (CDC’s) Advancing HIV
Prevention Initiative (AHP), Replicating
Effective Programs (REP), Diffusion of
Effective Behavioral Interventions
(DEBI), the Compendium of Effective
Behavioral Interventions, and other
CDC-supported strategies for specific
high-risk racial/ethnic minority
subpopulations.
As effective interventions and
adaptation and tailoring guidance are
developed, future funding cycles will
integrate the new science.
For migrant workers, the
interventions and public health
strategies should be consistent with
CDC-supported strategies for specific
high-risk racial/ethnic minority
subpopulations. Examples include the
community health outreach worker
(CHOW) model (also referred to as
Promotores/as, lay health advisors,
community health advisor networks or
peer educators), Real AIDS Prevention
Project (RAPP), other interventions from
REP and DEBI which are appropriate for
migrant worker populations.
For youth in non-school settings, a
number of evidence-based, scientifically
tested behavioral interventions have
been identified specifically for high-risk
youth, including Street Smart (for
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
homeless and runaway teens); Teens
Linked to Care (TLC) (for HIV-positive
persons ages 13–24); and Focus on Kids
(for out-of-school African-American
teens in poverty settings) [Stanton et al.,
(1996) Archives of Pediatrics and
Adolescent Medicine, 150 (4), 363–372].
All of the interventions for youth
supported by CDC contain abstinence
education, and comply with the ABC
Approach to HIV Prevention—
Information on HIV prevention methods
(or strategies) can include abstinence,
monogamy (i.e., being faithful to a
single sexual partner), or using condoms
consistently and correctly. These
approaches can avoid risk (abstinence)
or effectively reduce risk for HIV
(monogamy, consistent and correct
condom use).
Note: For this program announcement,
youth are defined as individuals between the
ages of 13 to 24 years who are at high risk
for HIV infection. Interventions for youth at
high risk are limited to out-of-school youth
in non-school settings. CBA providers are
expected to remind youth-focused
community-based organizations (CBO) that
they should be familiar with and adhere to
their own state’s rules and regulations related
to providing HIV prevention information to
youth (e.g., the age requirement for access to
services with or without parental consent).
Science-based behavioral HIV
prevention interventions listed in the
Procedural Guidance for Selected
Interventions and Strategies for
Community-Based Organizations, REP
and DEBI include: Recruitment and
retention; counseling, testing and
referral (CTR); prevention case
management (PCM); and partner
counseling, testing and referral services
(PCTRS).
For information on the Procedural
Guidance for Selected Interventions and
Strategies for Community-Based
Organizations mentioned above, visit
the following Internet address: https://
www.cdc.gov/hiv/partners/
pa04064_cbo.htm.
For information on the Compendium
of Effective Behavioral Interventions,
visit the following Internet address:
https://www.cdc.gov/hiv/pubs/
hivcompendium/HIVcompendium.htm
The term ‘‘adapt’’ refers to changes in
the target population or venue in which
an intervention takes place. The term
‘‘tailor’’ refers to changes in: (1) The
health message or activity; (2) the way
the message is delivered or by whom;
and (3) the timing of the message. TA is
training to adapt, tailor and evaluate
science-based behavioral HIV
prevention interventions for the specific
racial/ethnic/cultural high-risk minority
subpopulations of migrant workers,
transgender individuals, or youth in
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
non-school settings, including LGBTQ
youth.
Adaptation and tailoring of DEBI
products and public health strategies for
specific high-risk racial/ethnic minority
subpopulations of migrant workers,
transgender individuals, or youth in
non-school settings, including LGBTQ
youth, must be culturally and
linguistically appropriate. Fidelity of all
interventions and public health
strategies must be maintained by
adhering to their specific core elements.
This includes adapting and tailoring all
training curricula and written materials
on each intervention selected,
development of a national marketing
and diffusion plan for the adapted and
tailored interventions, and the provision
of CBA to implement adapted and
tailored interventions.
This program addresses the ‘‘Healthy
People 2010’’ focus area of HIV. This
program also addresses the goals stated
in CDC’s HIV Prevention Strategic Plan
through 2005, which can be found at
https://www.cdc.gov/hiv/partners/
psp.htm; and Advancing HIV
Prevention: New Strategies for a
Changing Epidemic at https://
www.cdc.gov/hiv/partners/ahp.htm.
Measurable outcomes of the program
will be in alignment with one (or more)
of the following performance goals for
the National Center for HIV, STD and
TB Prevention (NCHSTP):
1. Decrease the number of persons at
high risk for acquiring or transmitting
HIV infection.
2. By 2010, increase by 13 percent the
proportion of HIV-infected people who
know they are infected, as measured by
the proportion diagnosed before
progression to AIDS (Baseline: 76
percent in 2000; Target for 2010: 85
percent).
3. By 2010, increase to at least 80
percent the proportion of HIV-infected
people who are linked to appropriate
prevention, care, and treatment services,
as measured by those who report having
received some form of medical care
within three months of their HIV
diagnosis (2001 Baseline: 79 percent).
4. Strengthen the capacity to develop
and implement effective HIV prevention
interventions.
CBA developed under this program
will be categorized as Strengthening
Interventions for HIV Prevention
(designated as Focus Area [FA] 2) in the
CBA model, as referenced in
Attachment I.
Program Goals: The goal for this
program is to strengthen interventions
for HIV prevention by improving the
capacity of CBOs and health
departments to implement, improve,
and evaluate HIV prevention
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
19083
interventions specifically targeting highrisk racial/ethnic minority
subpopulations. The minority
subpopulations are migrant workers,
transgender individuals, and youth in
non-school settings, including lesbian/
gay/bisexual/transgender and
questioning (LGBTQ) youth.
This announcement is only for nonresearch activities supported by CDC. If
research is proposed, the application
will not be reviewed. For the definition
of research, please see the CDC website
at the following Internet address:
https://www.cdc.gov.od/ads/
opspoll1.htm.
Activities: Awardee activities for this
program are as follows: All applicants
are required to implement awardee
activities by developing process
objectives and activities for the
following:
1. Provide ongoing individualized
CBA to CDC’s directly funded CBOs,
health departments, and health
department-funded CBOs in the
adaptation, implementation, quality
assurance, and evaluation of effective
science-based behavioral HIV
prevention interventions for high-risk,
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth. CBA
providers will utilize CDC’s draft
adaptation guidance to: (a) Conduct
assessments of needs and community
resources; (b) identify and address gaps
in CBA services; (c) collaborate with
other sources of CBA (including other
CDC CBA providers and CBOs
specifically receiving CDC’s Program
Announcement 04064 ADAPT
supplemental for adapting and tailoring
DEBI interventions); (d) notify,
collaborate and coordinate with state
and local health departments in the
delivery of CBA services within their
health jurisdictions; and (e) leverage
other federal, state or local resources.
Examples of prevention interventions
are health education and risk reduction;
outreach capacity and preparation for
testing; HIV testing; referrals; prevention
and partner counseling; prevention case
management; interventions to prevent
perinatal transmission; and rapid testing
in non-traditional settings, such as
correctional facilities and high-risk
community venues.
2. Provide CBA to health departments
and their funded CBOs on culturally
appropriate HIV prevention
interventions and strategies for high-risk
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth. This
includes: (a) Obtaining and utilizing
E:\FR\FM\12APN1.SGM
12APN1
19084
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
input from high-risk, racial/ethnic
minority subpopulations of migrant
workers, transgender individuals, or
youth in non-school settings, including
LGBTQ youth proposed for this project;
and (b) incorporating cultural
competency and linguistic and
educational appropriateness into all
CBA activities.
CBA for HIV prevention may include
methods for practicing abstinence,
monogamy (i.e., being faithful to a
single sexual partner), or safer sex (i.e.,
using condoms consistently and
correctly). These approaches can avoid
risk or effectively reduce risk for HIV
infection.
Prevention interventions should also
include risk reduction and avoidance
for co-infections with other sexually
transmitted diseases, blood-borne
diseases (i.e., Hepatitis B and C), and
tuberculosis.
3. Work with CDC program
consultants and Science Application
Team technical monitors, who are
responsible for ensuring fidelity,
consistency, and support for the
delivery of evidence-based HIV
prevention interventions and strategies.
With their help, develop collaborative
partnerships with the originators of the
supported science-based interventions,
other social and behavioral scientists,
and public health experts to adapt and
tailor a minimum of two (2) sciencebased behavioral interventions for highrisk, racial/ethnic minority
subpopulations of migrant workers,
transgender individuals, or youth in
non-school settings, including LGBTQ
youth. These partners will be
responsible for reviewing all materials
produced to ensure fidelity to the
original intervention and for
collaborating on the delivery of CBA.
This includes: (a) Development of
adaptation and tailoring materials based
on CDC’s draft adaptation guidance on
each intervention; (b) provision of CBA,
including training and TA, on adapting
and tailoring science-based behavioral
HIV prevention interventions; and (c)
development of a national marketing
and diffusion plan for the interventions
in the CDC’s Procedural Guidance and
other CDC-supported strategies for
specific high-risk, racial/ethnic minority
subpopulations. Note: Specifically for
DEBI interventions, all materials related
to the adaptation and tailoring of the
interventions will need to be reviewed
by CDC program consultants, Science
Application Team technical monitors,
and original investigators, as
appropriate.
4. Collaborate with CDC, CDC-funded
CBA and TA providers, and locally
based partners and contractors to plan
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
and deliver CBA that is consistent with
the requirements of the DEBI
interventions and CDC program
requirements (as provided in trainings
for grantees) and avoids duplication of
services. This includes developing
training materials, diffusing best
program practices and interventions for
HIV-negative and HIV-positive persons,
and supporting partners with
orientation and training to help them
deliver effective and efficient services.
Note: To achieve cost-effectiveness,
other partners and experts contracted by
CBA providers should be locally based
and culturally competent.
5. Core Performance Indicators. To
ensure quality programs and to measure
progress, all applicants receiving
funding are required to report on the
following core performance indicators:
(a) Number of CDC-funded CBOs that
serve high-risk, racial/ethnic minority
subpopulations of migrant workers,
transgender individuals, or youth in
non-school settings, including LGBTQ
youth, receiving CBA on adapted and
tailored science-based behavioral
prevention interventions and public
health strategies that increase behaviors
that reduce risk for transmission or
acquisition of HIV.
(b) Number of health departmentfunded CBOs that serve high-risk,
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth,
receiving CBA on adapted and tailored
science-based behavioral prevention
interventions and public health
strategies that increase behaviors that
reduce risk for transmission or
acquisition of HIV.
(c) Number of CDC-funded CBOs that
report agreement with timeliness in
completion of CBA services.
(d) Number of health departmentfunded CBOs that report agreement with
timeliness in completion of CBA
services.
(e) Number of CDC-funded CBOs that
receive CBA and, in turn, deliver
adapted and tailored interventions and/
or public health strategies to high-risk,
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth.
(f) Number of health departmentfunded CBOs that receive CBA and, in
turn, deliver adapted and tailored
interventions and/or public health
strategies to high-risk, racial/ethnic
minority subpopulations of migrant
workers, transgender individuals, or
youth in non-school settings, including
LGBTQ youth.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
(g) Number of CDC-funded CBOs,
health department-funded CBOs, and
other stakeholders serving high-risk,
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth,
receiving CBA on implementing
realistic and feasible evaluation efforts
of adapted and tailored science-based
behavioral prevention interventions.
Applicants will be responsible for the
following in response to the
performance indicators:
(1) Set baseline, one-year, and fouryear target goals (target goals will be
negotiated with CDC post-award).
(2) Use performance indicators for the
design of a monitoring evaluation plan.
(3) Collect process and outcome
monitoring data and report to the CDC.
Applicants, with the substantial
involvement of CDC, will be
accountable for achieving performance
target goals. If an applicant fails to
achieve its target, CDC will work with
the applicant to determine what steps
can be taken to improve performance.
CDC involvement may include TA,
conditional or restrictive funding. If
applicant’s performance fails to
improve, CDC in accordance with
applicable federal regulations may take
enforcement actions such as, suspension
or termination of the Notice of Award
(NoA).
6. Implement an evaluationmonitoring plan based on logic
modeling that links outcomes (both
short- and long-term) with program
activities/processes and the theoretical
assumptions/principles of the program
performance indicators.
The plan should outline the process
and outcome data to be collected,
identify sources of information, explain
the methods by which information will
be collected, and outline the process for
analyzing and interpreting information,
and using findings for program
improvement.
7. Identify the CBA training needs of
your own program and staff. Develop
and implement a plan to address these
needs.
8. Develop protocols that respond to
new CBA requests, including
submission of notification and
completion of forms. Refer all CBA
requests outside your scope of work to
the CDC CBA coordinator responsible
for tracking and assigning CBA requests,
following procedures to be provided by
CDC.
9. Participate in CDC-coordinated
CBA networks to enhance
communication, coordination,
cooperation, and training.
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
10. Implement a quality assurance
strategy that ensures the delivery of
high-quality services.
11. Develop and implement an
effective strategy for marketing your
CBA services.
12. Report planned group CBA events
to the Capacity Building Branch (CBB)
Training Calendar, as provided by CDC,
for dissemination to HIV prevention
partners and constituents.
13. Facilitate the dissemination of
information about successful CBA
strategies and ‘‘lessons learned’’ through
peer-to-peer interactions, meetings,
workshops, conference presentations,
case studies, and communications with
CDC program consultants.
14. Take the Adaptation and Tailoring
course provided by the STD/HIV
Prevention Training Centers (PTC);
follow the adaptation and tailoring
guidance document, once it is
developed by CDC, and collaborate with
CDC behavioral and social scientists in
developing adapted and tailored
materials for the behavioral
interventions.
15. Coordinate with local and state
health departments prior to providing
CBA services.
16. Attend all post-award training
events.
17. Submit materials developed with
funding through this program
announcement to the CDC National
Prevention Information Network (NPIN)
for access by the public free of charge
and dissemination by NPIN.
18. Check with the CDC NPIN to
determine if suitable materials are
already available. For further
information on NPIN services and
resources, contact NPIN at 1–800–458–
5231; visit its website at
www.cdcnpin.org; or send requests by
fax to 1–888–282–7681 (TTY users: 1–
800–243–7012).
In a cooperative agreement, CDC staff
is substantially involved in the program
activities, above and beyond routine
grant monitoring.
CDC activities for this program are as
follows:
1. Support all funded awardees by
coordinating national networks of
capacity building providers.
2. Provide consultation and TA in
designing, planning, developing,
operating, and evaluating activities
(such as progress reporting, submitting
information for the training calendar,
etc.) based on CDC’s standards and CDC
program requirements. CDC may
provide consultation and TA both
directly from CDC and indirectly
through prevention partners, such as
health departments, national and
regional minority partners, CBA
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
partners, trainers, contractors, and other
national organizations.
3. Monitor the performance of
program and fiscal activities through
progress reports, data reporting, site
visits, conference calls, and ensuring
compliance with federally mandated
requirements, such as use of a materials
review panel and internal audit
procedures.
4. Add or refine performance
indicators over the course of the project
period. (For additional information on
performance indicators, see Application
and Submission Information thru
NPIN.)
5. Provide up-to-date scientific
information and training on the risk
factors for transmitting HIV infection
among persons living with HIV/AIDS;
HIV prevention services for individual
and partner counseling, HIV testing, and
referral to care and treatment; and
proven effective behavioral
interventions for people at risk for
transmitting HIV or becoming infected.
6. Provide up-to-date information and
training on CDC’s draft adaptation
guidance developed by CDC with input
from internal and external researchers,
HIV prevention intervention
implementers and community
advocates.
7. Assist in the development of
collaborative efforts with state and local
health departments, HIV prevention
community planning groups, CBOs that
receive direct funding from CDC, and
other federally supported organizations
providing HIV/AIDS services.
8. Facilitate the exchange of
information about successful
interventions, program models, and
‘‘lessons learned’’ through grantee
meetings, workshops, conferences,
newsletters, the Internet, and
communications with CDC project
officers. CDC will also facilitate the
exchange of program information and
TA among community-based
organizations, health departments, and
national and regional organizations.
9. Ensure that any products developed
with these funds reflect both cultural
competence and sound evidence-based
science. These products must first be
reviewed and cleared by the original
behavioral scientist(s) for the selected
DEBI intervention(s) before submitting
them to CDC for clearance.
10. Conduct an overall evaluation of
the project.
11. Disseminate CBA Training
Calendar of training activities.
II. Award Information
Type of Award: Cooperative
Agreement. CDC involvement in this
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
19085
program is listed in the Activities
Section above.
Fiscal Year Funds: 2005.
Approximate Total Funding:
$2,876,000 (This amount is an estimate
and is subject to availability of funds.).
Approximate Number of Awards: Six
(6).
Approximate Average Award:
$440,000 (This amount is for the first
12-month budget period and includes
both direct and indirect costs.).
Floor of Award Range: $400,000.
Ceiling of Award Range: $500,000
(This ceiling is for the first 12-month
budget period.).
Anticipated Award Date: August 1,
2005.
Budget Period Length: 12 months.
Project Period Length: Four (4) years.
Throughout the project period, CDC’s
commitment to the continuation of
awards will be conditioned on the
availability of funds, evidence of
satisfactory progress by the recipient (as
documented in required reports), and
the determination that continued
funding is in the best interest of the
Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by
public and private nonprofit
organizations, such as:
• Public nonprofit organizations.
• Private nonprofit organizations.
• Universities.
• Colleges.
• Community-based organizations.
• Faith-based organizations.
• Federally recognized Indian tribal
government.
• Indian tribal organizations.
III.2. Cost-Sharing or Matching
Matching funds are not required for
this program.
III.3. Other
If you request a funding amount
greater than the ceiling of the award
range, your application will be
considered non-responsive and will not
be entered into the review process. You
will be notified that your application
did not meet the submission
requirements.
Special Requirements: If your
application is incomplete or nonresponsive to the special requirements
listed in this section, it will not be
entered into the review process. You
will be notified that your application
did not meet submission requirements.
• Applicants must provide proof of
eligibility as outlined in Section IV.2. of
this announcement.
E:\FR\FM\12APN1.SGM
12APN1
19086
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
• All applicants will be required to
provide CBA within the United States
and its Territories.
• Late applications will be considered
non-responsive. See section ‘‘IV.3.
Submission Dates and Times’’ for more
information on deadlines.
• Governmental, municipal agencies
or affiliates of governmental or
municipal agencies (e.g., health
departments, school boards, public
hospitals) are not eligible to apply.
• Organizations currently receiving
more than one award for capacity
building assistance from CDC’s Capacity
Building Branch are not eligible to
apply.
• A minimum of two interventions or
CDC-supported strategies, listed in the
‘‘Purpose’’ section, must be adapted and
tailored for high-risk, racial/ethnic
minority subpopulations of migrant
workers, transgender individuals, or
youth in non-school settings, including
LGBTQ youth. For additional
information about interventions and
CDC-supported strategies, please visit:
https://www.cdc.gov/hiv/partners/
pa04064_cbo.htm and https://
www.cdc.gov/hiv/pubs/
hivcompendium/HIVcompendium.htm.
• Preference will be given to
organizations that provide evidence of
having previously adapted and tailored
interventions listed under the
‘‘Purpose’’ section for migrant workers,
transgender individuals, or youth in
non-school settings, including LGBTQ
youth.
• CDC may allocate additional
funding to this program announcement
to provide CBA as described in this
announcement to reach organizations
specifically targeting underserved
Latino/a youth at risk for HIV and STDs
(i.e., high-risk runaway Latino/a youth
engaging in survival activities such as
sex in exchange for drugs, money,
shelter, or food).
Note: Title 2 of the United States Code
Section 1611 states that an organization
described in Section 501(c)(4) of the Internal
Revenue Code that engages in lobbying
activities is not eligible to receive Federal
funds constituting an award, grant, or loan.
IV. Application and Submission
Information
IV.1. Address To Request Application
Package
To apply for this funding opportunity,
use application form PHS 5161–1.
CDC strongly encourages you to
submit your application electronically
by utilizing the forms and instructions
posted for this announcement at
www.grants.gov.
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
Application forms and instructions
are available on the CDC website, at the
following Internet address:
www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the
Internet, or if you have difficulty
accessing the forms online, you may
contact the CDC Procurement and
Grants Office Technical Information
Management Section (PGO–TIM) staff
at: 770–488–2700. Application forms
can be mailed to you.
To request an application kit (which
includes the request for application,
required forms, supplemental
information, CBA Guidelines, and other
information), contact CDC’s National
Prevention Information Network (NPIN)
at 1–800–458–5231; visit its website at
https://www.cdcnpin.org; or send
requests by fax to 1–888–282–7681
(TTY users: 1–800–243–7012). This
announcement and associated forms can
also be found on the CDC Internet home
page, https://www.cdc.gov. Click on
Funding Opportunities then Grants and
Cooperative Agreements.
transgender individuals, or youth in
non-school settings, including LGBTQ
youth, for whom you propose to adapt
and tailor interventions or CDCsupported strategies.
b. A description of all the sciencebased behavioral interventions or CDCsupported strategies you propose to
adapt and tailor.
c. A description of your strategy that
includes: (1) All interventions
previously adapted; (2) the proposed
overall marketing and diffusion plan; (3)
the overall evaluation plan; and (4) the
proposed plan to deliver CBA
nationally.
d. A description of your
organization’s three-year record of
experience providing CBA to consumers
that serve a major racial/ethnic minority
population listed above or of providing
direct HIV prevention services to a
major racial/ethnic minority population.
IV.2. Content and Form of Submission
a. Proposed Plan
Application: You must submit a
project narrative with your application
forms. The narrative must be submitted
in the following format:
• Maximum number of pages: 40
pages (excluding budget, appendices
and attachments). If your narrative
exceeds the page limit, only the first
pages which are within the page limit
will be reviewed.
• Font size: 12 point unreduced.
• All material must be typewritten;
single-spaced.
• Paper size: 8.5 x 11 inches.
• Page margin size: One inch.
• Printed only on one side of page.
• Held together only by rubber bands
or metal clips; not bound in any other
way.
• Program announcement title and
number must appear on each page of the
application.
• Number each page sequentially,
including appendices and attachments,
and provide a complete table of contents
to the application, its appendices and
attachments.
Narrative. Your narrative should
address activities to be conducted over
the entire project period, and must
include the following items in the order
listed:
A description of your proposed plan
for building capacity for adapting,
tailoring and implementing
interventions listed in the ‘‘Purpose’’
section of this announcement. In
addition, include a description of the
HIV prevention interventions you have
previously adapted and tailored,
including training and TA delivered.
Include epidemiological evidence and
other quantitative and qualitative data
to support your proposed program plan.
1. Abstract
Please provide a brief four-page
summary of the proposed program
activities, including the following
information:
a. A description of the high-risk
subpopulation of migrant workers,
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
2. Program Plan
The program plan should include the
following:
b. Objectives
What are your proposed specific,
measurable, appropriate, realistic and
time-phased (SMART) objectives to
address the awardee activities?
c. Activities
List and describe the proposed
activities that relate to each of the
objectives listed above.
d. Timeline
Provide a time line and list staff
responsible for accomplishing and
implementing activities in the first year.
3. Program Experience
a. Describe your organization’s
program experience as it relates to
providing CBA nationally, including
training and TA on adapting, tailoring,
marketing and evaluating science-based
behavioral HIV prevention
interventions.
b. Describe the methods and
recipients of CBA services previously
provided by your organization.
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
c. Describe your organization’s
program experience collaborating with
behavioral science researchers as well as
other HIV prevention agencies,
including state and local health
departments.
d. Describe your organization’s
program experience in providing CBA
that responds effectively to the cultural,
gender, environmental, social, and
linguistic characteristics of your
proposed high-risk subpopulation of
migrant workers, transgender
individuals, or youth in non-school
settings, including LGBTQ youth. In
answering this question, describe the
types of services provided and list any
culturally, linguistically, and
developmentally appropriate curricula
and materials that your organization has
adapted or developed.
4. Organizational Capacity
a. Indicate where the proposed
program will be located within the
organization (e.g., within the Office of
the Executive Director, the Health
Services Department, the HIV
Prevention Section/Department, etc.).
b. Describe your fiscal management
system and how it functions.
c. Describe your human resource
management system and how it
functions.
d. Describe your Management
Information System (MIS), including
functional role and software assets.
e. Summarize how the systems and
assets described above will be used to
support and manage the proposed
program.
f. Provide the number of your fulltime employees (FTEs) and describe
their expertise related to social/
behavioral science, curriculum
development, training, marketing, and
evaluation.
5. Evaluation Monitoring Plan
a. Provide baseline, one-year interim
and four-year overall target performance
goals based on the core performance
indicators.
b. Describe the process and outcome
data you will collect. Note: Data
collected must relate to your objectives
and the performance indicators.
c. Describe the methods for collecting,
analyzing, interpreting, and reporting
your process and outcome data.
d. Describe the plans for using your
process and outcome data to improve
the program.
6. Budget and Staffing Breakdown and
Justification (Not Included in Narrative
Page Limit)
a. Provide a detailed budget for each
proposed activity. Justify all operating
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
expenses in relation to the planned
objectives and related activities. CDC
may not approve or fund all proposed
activities. Be precise about the
justification for each budget item and
itemize calculations wherever
appropriate.
b. For each contract and consultant
contained within the application
budget, describe the type(s) of
organizations or parties to be selected
and the method of selection; identify the
specific contractor(s), if known; and
describe the expertise related to
behavioral science, curriculum
development, training, marketing, and
evaluation. Describe services to be
performed, and justify the use of a third
party to perform these services; provide
a breakdown of and justification for the
estimated costs of the contractors and
consultants; specify the period of
performance; and describe the methods
to be used for contract monitoring.
c. Provide a job description for each
position, specifying job title, function,
general duties, activities and expertise
related to behavioral science,
curriculum development, training,
marketing, and evaluation. Also provide
salary range or rate of pay, and the level
of effort and percentage of time, to be
spent on activities that would be funded
through this cooperative agreement. If
the identity of any key personnel who
will fill a position is known, his/her
name and resume should be included in
the appendix section. Experience and
training related to the proposed project
should be noted. If the identity of staff
is not known, describe your recruitment
plan. If volunteers are involved in the
project, provide their job descriptions
and expertise related to behavioral
science, curriculum development,
training, marketing, and evaluation.
7. Proof of Eligibility
Applicants must complete the
following section on proof of eligibility,
including providing the following
documents as appropriate. Include
eligibility documentation as
‘‘Attachment A.’’
Applications without the required
documentation will be considered nonresponsive.
• CBA developed under this program
announcement will be delivered to CBA
consumers serving one or more of the
four major racial/ethnic populations as
follows:
• Black/African American
• Hispanic/Latino
• Asian/Pacific Islander
• American Indian/Alaska Native
• Documentation that your
organization has the specific charge
from its executive board or governing
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
19087
body to operate nationally within the
United States and its Territories.
Documentation should include a copy
of the statement from your
organization’s Articles of Incorporation,
Bylaws, or Board Resolution.
• A copy of the current, valid Internal
Revenue Service (IRS) determination
letter of your organization’s 501(c)3 taxexempt status.
• Evidence that your organization has
been in operation for three years as
documented by annual agency reports, a
board resolution, or other
documentation.
• Evidence that your organization has
a three-year record of experience, as
documented by annual agency reports, a
board resolution, or other
documentation, in the following:
1. Providing CBA to CBOs and health
departments on adapting, tailoring and
implementing science-based behavioral
HIV prevention interventions for highrisk, racial/ethnic minority
subpopulations of migrant workers,
transgender individuals, or youth in
non-school settings including LGBTQ
youth for which you are applying.
2. Providing CBA to CBOs and health
departments that serve a major racial/
ethnic minority population(s) listed
above, or providing direct HIV
prevention services to a major racial/
ethnic minority population. In order to
enhance program efficacy and facilitate
learning, applicants must demonstrate
cultural competence, including access
to and credibility with the targeted
populations mentioned above.
Additional information may be
included in the application appendices.
The appendices will not be counted
toward the narrative page limit. This
additional information includes
curriculum vitaes, resumes,
organizational charts, letters of support,
etc.
You are required to have a Dun and
Bradstreet Data Universal Numbering
System (DUNS) number to apply for a
grant or cooperative agreement from the
Federal government. The DUNS number
is a nine-digit identification number,
which uniquely identifies business
entities. Obtaining a DUNS number is
easy and there is no charge. To obtain
a DUNS number, access https://
www.dunandbradstreet.com or call 1–
866–705–5711.
For more information, see the CDC
website at: https://www.cdc.gov/od/pgo/
funding/pubcommt.htm. If your
application form does not have a DUNS
number field, please write your DUNS
number at the top of the first page of
your application, and/or include your
DUNS number in your application cover
letter.
E:\FR\FM\12APN1.SGM
12APN1
19088
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
Additional requirements that may
require you to submit additional
documentation with your application
are listed in section ‘‘VI.2.
Administrative and National Policy
Requirements.’’
application instructions. If your
submission does not meet the deadline
above, it will not be eligible for review,
and will be discarded. You will be
notified that you did not meet the
submission requirements.
IV.3. Submission Dates and Times
Application Deadline Date: May 27,
2005.
Explanation of Deadlines:
Applications must be received in the
CDC Procurement and Grants Office by
4 p.m. Eastern Time on the deadline
date.
You may submit your application
electronically at www.grants.gov.
Applications completed online through
Grants.gov are considered formally
submitted when the applicant
organization’s Authorizing Official
electronically submits the application to
www.grants.gov. Electronic applications
will be considered as having met the
deadline if the application has been
submitted electronically by the
applicant organization’s Authorizing
Official to Grants.gov on or before the
deadline date and time.
If you submit your application
electronically with Grants.gov, your
application will be electronically time/
date stamped, which will serve as
receipt of submission. You will receive
an e-mail notice of receipt when CDC
receives the application.
If you submit your application by the
United States Postal Service or
commercial delivery service, you must
ensure that the carrier will be able to
guarantee delivery by the closing date
and time. If CDC receives your
submission after closing due to: (1)
Carrier error, when the carrier accepted
the package with a guarantee for
delivery by the closing date and time, or
(2) significant weather delays or natural
disasters, you will be given the
opportunity to submit documentation of
the carrier’s guarantee. If the
documentation verifies a carrier
problem, CDC will consider the
submission as having been received by
the deadline.
If you submit a hard copy application,
CDC will not notify you upon receipt of
your submission. If you have a question
about the receipt of your application,
first contact your courier. If you still
have a question, contact the PGO–TIM
staff at: 770–488–2700. Before calling,
please wait two to three days after the
submission deadline. This will allow
time for submissions to be processed
and logged.
This announcement is the definitive
guide on application content,
submission address, and deadline. It
supersedes information provided in the
IV.4. Intergovernmental Review of
Applications
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
Your application is subject to
Intergovernmental Review of Federal
Programs, as governed by Executive
Order (EO) 12372. This order sets up a
system for state and local governmental
review of proposed federal assistance
applications. You should contact your
state single point of contact (SPOC) as
early as possible to alert the SPOC to
prospective applications and to receive
instructions on your state’s process.
Click on the following link to get the
current SPOC list: https://
www.whitehouse.gov/omb/grants/
spoc.html.
IV.5. Funding Restrictions
Restrictions, which must be taken into
account while writing your budget, are
as follows:
• Funds may not be used for research.
• Reimbursement of pre-award costs
is not allowed.
• Funds available under this
announcement must:
a. Support CBA that improves the
capacity of the CBOs to implement,
improve, and sustain programs that
support the delivery of effective HIV
prevention services for high-risk, racial/
ethnic minority sub-populations.
b. Support CBA that gives priority to
CBOs directly funded by CDC, followed
by CBOs funded by state and local
health departments.
c. Not supplant or duplicate existing
funding.
d. Not be used to provide direct
provision of health education and risk
reduction and avoidance (HERR)
services or patient care, including
substance abuse treatment, medical
treatment, or medications.
e. Not be used to support the cost of
developing applications for other
federal funds.
• Organizations receiving award must
directly provide the majority of CBA
services by their employed staff.
Note: All work provided by subcontractors
is subject to approval and the applicant may
not receive an award if proposed
subcontractors are providing the majority of
CBA services.
Funding estimates and project period
may change based on the availability of
funds, scope of work, and quality of the
applications received, appropriateness
and reasonableness of the budget
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
justifications, and proposed use of
project funds.
If you are requesting indirect costs in
your budget, you must include a copy
of your indirect cost rate agreement. If
your indirect cost rate is a provisional
rate, the agreement must be less than 12
months of age.
Guidance for completing your budget
can be found on the CDC website, at the
following Internet address: https://
www.cdc.gov/od/pgo/funding/
budgetguide.htm.
IV.6. Other Submission Requirements
Application Submission Address:
CDC strongly encourages applicants to
submit electronically at:
www.grants.gov. You will be able to
download a copy of the application
package from www.grants.gov, complete
it offline, and then upload and submit
the application via the Grants.gov site.
E-mail submission will not be accepted.
If you are having technical difficulties
in Grants.gov, they can be reached by email at www.support@grants.gov or by
phone at 1–800–518–4726 (1–800–
GRANTS). The Customer Support
Center is open from 7 a.m. to 9 p.m.
Eastern Time, Monday through Friday.
CDC recommends that you submit
your application to Grants.gov early
enough to resolve any unanticipated
difficulties prior to the deadline. You
may also submit a back-up paper
submission of your application. Any
such paper submission must be received
in accordance with the requirements for
timely submission detailed in Section
IV.3. of the grant announcement. The
paper submission must be clearly
marked: ‘‘BACK-UP FOR ELECTRONIC
SUBMISSION.’’
The paper submission must conform
to all requirements for non-electronic
submissions. If both electronic and
back-up paper submissions are received
by the deadline, the electronic version
will be considered the official
submission.
It is strongly recommended that you
submit your grant application using
Microsoft Office products (e.g.,
Microsoft Office, Microsoft Excel, etc.).
If you do not have access to Microsoft
Office products, you may submit a PDF
file. Directions for creating PDF files can
be found on the Grants.gov web site.
Use of file formats other than Microsoft
Office or PDF may result in your file
being unreadable by our staff.
OR
Submit the original and two hard
copies of your application by mail or
express delivery service to: Technical
Information Management—RFA# 05051,
CDC Procurement and Grants Office,
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
2920 Brandywine Road, Atlanta, GA
30341.
V. Application Review Information
V.1. Criteria
Applicants are required to provide
measures of effectiveness that will
demonstrate the accomplishment of the
various identified objectives of the
cooperative agreement. Measures of
effectiveness must relate to the
performance goals stated in the
‘‘Purpose’’ section of this
announcement. Measures must be
objective and quantitative, and must
measure the intended outcome. These
measures of effectiveness must be
submitted with the application and will
be an element of evaluation.
Your application will be evaluated
against the following criteria:
1. Program Plan (40 Points)
a. Is the program based on highprevalence epidemiological evidence
and other concrete quantitative and
qualitative data? (10 points)
b. Are the proposed program
objectives specific, measurable,
appropriate, realistic, and time-phased?
(10 points)
c. What is the likelihood that the
proposed program activities will
accomplish the proposed program
objectives? (10 points)
d. Is the timeline feasible? (10 points)
2. Program Experience (20 Points)
Is the applicant’s program experience
relevant to adapting and tailoring
science-based behavioral HIV
prevention interventions, curriculum
development, training and TA,
marketing, and evaluation for high-risk
racial/ethnic minority subpopulations of
migrant workers, transgender
individuals, or youth in non-school
settings including LGBTQ youth?
3. Organizational Capacity (20 Points)
Does the applicant demonstrate
current organizational capacity to adapt,
tailor, implement, and evaluate HIV
interventions for high-risk racial/ethnic
minority subpopulations of migrant
workers, transgender individuals, or
youth in non-school settings including
LGBTQ youth?
4. Evaluation-Monitoring Plan (20
Points)
Is the evaluation-monitoring plan
feasible and does it address the required
performance indicators, process and
outcome data collection, analysis, and
reporting activities?
V.2. Review and Selection Process
Applications will be reviewed for
completeness by the Procurement and
VerDate jul<14>2003
18:08 Apr 11, 2005
Jkt 205001
Grants Office (PGO) staff, and for
responsiveness by National Center for
HIV, STD and TB Prevention
(NCHSTP)/Division of HIV and AIDS
Prevention (DHAP)/Capacity Building
Branch (CBB). Incomplete applications
and applications that are nonresponsive to the eligibility criteria will
not advance through the review process.
Applicants will be notified that their
application did not meet submission
requirements.
A Special Emphasis Review Panel
consisting of external experts will
evaluate complete and responsive
applications according to the criteria
listed in the ‘‘V.1. Criteria’’ section
above.
In addition, the following factors may
affect the funding decision:
1. CDC’s commitment to ensure
overall funding for CBA services that
serve each of the four major racial/
ethnic minority populations.
2. CDC’s commitment to ensure
overall funding for CBA services, which
is distributed in proportion to the HIV/
AIDS disease burden among high-risk
racial/ethnic minority sub-populations.
3. CDC’s commitment to ensure that
CBA funding will include different
high-risk racial/ethnic minority
subpopulations of migrant workers,
transgender individuals, or youth in
non-school settings including LGBTQ
youth.
4. Preference will be given to
organizations that provide evidence of
having previously adapted and tailored
interventions listed under the
‘‘Purpose’’ section for migrant workers,
transgender individuals, or youth in
non-school settings, including LGBTQ
youth.
5. CDC may allocate additional
funding to this program announcement
to provide CBA as described in this
announcement to reach organizations
specifically targeting underserved
Latino/a youth at risk for HIV and STDs
(i.e., high-risk runaway Latino/a youth
engaging in survival activities such as
sex in exchange for drugs, money,
shelter, or food).
CDC will provide justification for any
decision to fund out of rank order.
V.3. Anticipated Announcement and
Award Dates
Anticipated Award Date: August 1,
2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a
Notice of Award (NoA) from the CDC
Procurement and Grants Office. The
NoA shall be the only binding,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
19089
authorizing document between the
recipient and CDC. The NoA will be
signed by an authorized Grants
Management Officer and mailed to the
recipient fiscal officer identified in the
application.
Unsuccessful applicants will receive
notification of the results of the
application review by mail.
VI.2. Administrative and National
Policy Requirements
45 CFR Parts 74 and 92
For more information on the Code of
Federal Regulations, see the National
Archives and Records Administration at
the following Internet address: https://
www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.
The following additional
requirements apply to this project:
• AR–4 HIV/AIDS Confidentiality
Provisions
• AR–5 HIV Program Review Panel
Requirements
• AR–7 Executive Order 12372 Review
• AR–8 Public Health System
Reporting Requirements
• AR–9 Paperwork Reduction Act
Requirements
• AR–10 Smoke-Free Workplace
Requirements
• AR–11 Healthy People 2010
• AR–12 Lobbying Restrictions
• AR–14 Accounting System
Requirements
• AR–15 Proof of Non-Profit Status
• AR–20 Conference Support
• AR–21 Small, Minority, and WomenOwned Business
• AR–23 States and Faith-Based
Organizations
• AR–25 Release and Sharing of Data
Additional information on these
requirements can be found on the CDC
website at the following Internet
address: https://www.cdc.gov/od/pgo/
funding/ARs.htm.
An additional Certifications form
from the PHS 5161–1 application needs
to be included in your Grants.gov
electronic submission only. Refer to
https://www.cdc.gov/od/pgo/funding/
PHS5161-1Certificates.pdf. Once the
form is filled out, attach it to your
Grants.gov submission as Other
Attachment Forms.
VI.3. Reporting Requirements
You must provide CDC with an
original plus two hard copies of the
following reports:
1. First trimester progress report, due
30 days after the first four (4) months of
the project period. The report must
contain the following elements:
a. Current Budget Period Activities
Objectives.
E:\FR\FM\12APN1.SGM
12APN1
19090
Federal Register / Vol. 70, No. 69 / Tuesday, April 12, 2005 / Notices
b. Current Budget Period Financial
Progress.
c. New Budget Period Program
Proposed Activity Objectives.
d. Budget.
e. Measures of effectiveness.
f. Additional requested information,
including (1) data related to
performance target goals; (2) data on
progress toward achieving objectives; (3)
an inventory of total individual capacity
building assistance and proactive
training for the reporting period; and (4)
data related to the quality assurance
system.
2. Second trimester interim progress
report shall be due 30 days after the
completion of the first eight (8) months
of the project period. This second
trimester progress report will serve as
your non-competing continuation
application for the next funding cycle.
(See Continuing Application
Requirements provided by Procurement
and Grants Office.) This report must
include elements a–f, as listed in the
first trimester report, and be completed
during this time period (months 5–8).
The report should also include the
following:
a. Base line and actual level of core
performance indicators.
b. Specific guidance, which will be
provided by the CDC three months prior
to the due date.
3. The third trimester progress report
shall be due 30 days after the end of the
budget period. This report must include
elements a–f as listed in the first
trimester report, elements a–b as listed
in the second trimester report, and
completed during this time period
(months 9–12).
4. Financial status report is due no
more than 90 days after the end of the
budget period.
5. Final financial and performance
reports are due no more than 90 days
after the end of the project period.
These reports must be mailed to the
Grants Management or Contract
Specialist listed in the ‘‘Agency
Contacts’’ section of this announcement.
VII. Agency Contacts
We encourage inquiries concerning
this announcement.
For Pre-application Technical
Consultation: Send questions regarding
this application to
DHAPCBAPT@CDC.GOV. You will
receive a response within 24–48 hours.
For general questions, contact:
Technical Information Management
Section, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta,
GA 30341. Telephone: 770–488–2700.
For program technical assistance,
contact: Gerlinda Gallegos Somerville,
VerDate jul<14>2003
16:48 Apr 11, 2005
Jkt 205001
Public Health Analyst, Centers for
Disease Control and Prevention,
National Center for HIV, STD, and TB
Prevention, Division of HIV/AIDS
Prevention, Capacity Building Branch,
1600 Clifton Road, Mailstop E–40,
Atlanta, GA 30333, Telephone: 404–
639–2918. E-mail address:
DHAPCBAPT@CDC.GOV.
For financial, grants management, or
budget assistance, contact: Roslyn
Curington, Grants Management
Specialist, Centers for Disease Control
and Prevention, Procurement and
Grants Office, 2920 Brandywine Road,
Room 3000, Atlanta, Georgia 30341–
4146. Telephone: 770–488–2767, E-mail
address: zlp8@cdc.gov.
VIII. Other Information
This and other CDC funding
opportunity announcements can be
found on the CDC Web site, Internet
address: www.cdc.gov. Click on
‘‘Funding’’ then ‘‘Grants and
Cooperative Agreements.’’
Dated: April 6, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–7286 Filed 4–11–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–5033–N6]
Medicare Program; Cancellation of the
April 13, 2005 Advisory Board Meeting
on the Demonstration of a Bundled
Case-Mix Adjusted Payment System
for End-Stage Renal Disease Services
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Cancellation of meeting.
AGENCY:
This notice cancels the April
13, 2005 Advisory Board Meeting on the
Demonstration of a Bundled Case-Mix
Adjusted Payment System for End-Stage
Renal Disease (ESRD) Services. We
published the meeting notice in the
Federal Register on March 25, 2005 (70
FR 15343).
DATES: Effective Date: The notice
announcing the cancellation of the
meeting is effective April 12, 2005.
FOR FURTHER INFORMATION CONTACT:
Pamela Kelly by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or
telephone at (410) 786–2461.
SUPPLEMENTARY INFORMATION: On June 2,
2004, we published a Federal Register
notice requesting nominations for
individuals to serve on the Advisory
Board on the Demonstration of a
Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease
(ESRD) Services. The June 2, 2004
notice also announced the
establishment of the Advisory Board
and the signing by the Secretary on May
11, 2004 of the charter establishing the
Advisory Board. On January 28, 2005,
we published a Federal Register notice
(70 FR 4132) announcing the
appointment of eleven individuals to
serve as members of the Advisory Board
on the Demonstration of a Bundled
Case-Mix Adjusted Payment System for
ESRD Services, including one
individual to serve as co-chairperson,
and one additional co-chairperson, who
is employed by CMS. The first public
meeting of the Advisory Board was held
on February 16, 2005. The second
public meeting of the Advisory Board
scheduled for April 13, 2005 has been
cancelled.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program)
Dated: April 7, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–7408 Filed 4–8–05; 1:51 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Cooperative Agreement to Support the
World Health Organization
International Programme on Chemical
Safety
AGENCY:
ACTION:
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Food and Drug Administration,
HHS.
Notice.
I. Funding Opportunity Description
The Food and Drug Administration
(FDA) is announcing its intent to accept
and consider a single source application
for the award of a cooperative agreement
to the World Health Organization
(WHO) to support the International
Programme on Chemical Safety (IPCS).
FDA anticipates providing $90,000
(direct and indirect costs) in fiscal year
2005 in support of this project. Subject
to the availability of Federal funds and
successful performance, 2 additional
years of support up to $90,000 per year
(direct and indirect costs) will be
available. FDA will support the research
E:\FR\FM\12APN1.SGM
12APN1
Agencies
[Federal Register Volume 70, Number 69 (Tuesday, April 12, 2005)]
[Notices]
[Pages 19082-19090]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7286]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Capacity Building Assistance To Improve the Delivery and
Effectiveness of Human Immunodeficiency Virus (HIV) Prevention
Interventions for High-Risk Racial/Ethnic Minority Subpopulations
Announcement Type: New.
Funding Opportunity Number: RFA 05051.
Catalog of Federal Domestic Assistance Number: 93.939.
Application Deadline: May 27, 2005.
I. Funding Opportunity Description
Authority: This program is authorized under Sections 301(a) and
317(k)(2) of the Public Health Service Act, 42 U.S.C. Sections 241 and
247b(k)(2).
Purpose: The purpose of this announcement is to provide financial
assistance to non-governmental HIV prevention organizations to provide
capacity building assistance (CBA), including training and technical
assistance (TA), to adapt, tailor and implement science-based,
behavioral HIV prevention interventions specifically targeting high-
risk racial/ethnic minority subpopulations as demonstrated by high-
prevalence epidemiological evidence and other concrete quantitative and
qualitative data. The minority subpopulations are migrant workers,
transgender individuals, and youth in non-school settings, including
lesbian/gay/bisexual/transgender and questioning (LGBTQ) youth.
The term ``capacity building assistance'' or ``CBA'' means the
provision of information, TA, training, and technology transfer for
individuals and organizations to improve the delivery and effectiveness
of HIV prevention services. CBA does not include the delivery of direct
client HIV prevention services and interventions.
CBA provided must be consistent with the Centers for Disease
Control and Prevention's (CDC's) Advancing HIV Prevention Initiative
(AHP), Replicating Effective Programs (REP), Diffusion of Effective
Behavioral Interventions (DEBI), the Compendium of Effective Behavioral
Interventions, and other CDC-supported strategies for specific high-
risk racial/ethnic minority subpopulations.
As effective interventions and adaptation and tailoring guidance
are developed, future funding cycles will integrate the new science.
For migrant workers, the interventions and public health strategies
should be consistent with CDC-supported strategies for specific high-
risk racial/ethnic minority subpopulations. Examples include the
community health outreach worker (CHOW) model (also referred to as
Promotores/as, lay health advisors, community health advisor networks
or peer educators), Real AIDS Prevention Project (RAPP), other
interventions from REP and DEBI which are appropriate for migrant
worker populations.
For youth in non-school settings, a number of evidence-based,
scientifically tested behavioral interventions have been identified
specifically for high-risk youth, including Street Smart (for
[[Page 19083]]
homeless and runaway teens); Teens Linked to Care (TLC) (for HIV-
positive persons ages 13-24); and Focus on Kids (for out-of-school
African-American teens in poverty settings) [Stanton et al., (1996)
Archives of Pediatrics and Adolescent Medicine, 150 (4), 363-372]. All
of the interventions for youth supported by CDC contain abstinence
education, and comply with the ABC Approach to HIV Prevention--
Information on HIV prevention methods (or strategies) can include
abstinence, monogamy (i.e., being faithful to a single sexual partner),
or using condoms consistently and correctly. These approaches can avoid
risk (abstinence) or effectively reduce risk for HIV (monogamy,
consistent and correct condom use).
Note: For this program announcement, youth are defined as
individuals between the ages of 13 to 24 years who are at high risk
for HIV infection. Interventions for youth at high risk are limited
to out-of-school youth in non-school settings. CBA providers are
expected to remind youth-focused community-based organizations (CBO)
that they should be familiar with and adhere to their own state's
rules and regulations related to providing HIV prevention
information to youth (e.g., the age requirement for access to
services with or without parental consent).
Science-based behavioral HIV prevention interventions listed in the
Procedural Guidance for Selected Interventions and Strategies for
Community-Based Organizations, REP and DEBI include: Recruitment and
retention; counseling, testing and referral (CTR); prevention case
management (PCM); and partner counseling, testing and referral services
(PCTRS).
For information on the Procedural Guidance for Selected
Interventions and Strategies for Community-Based Organizations
mentioned above, visit the following Internet address: https://
www.cdc.gov/hiv/partners/pa04064_cbo.htm.
For information on the Compendium of Effective Behavioral
Interventions, visit the following Internet address: https://
www.cdc.gov/hiv/pubs/hivcompendium/HIVcompendium.htm
The term ``adapt'' refers to changes in the target population or
venue in which an intervention takes place. The term ``tailor'' refers
to changes in: (1) The health message or activity; (2) the way the
message is delivered or by whom; and (3) the timing of the message. TA
is training to adapt, tailor and evaluate science-based behavioral HIV
prevention interventions for the specific racial/ethnic/cultural high-
risk minority subpopulations of migrant workers, transgender
individuals, or youth in non-school settings, including LGBTQ youth.
Adaptation and tailoring of DEBI products and public health
strategies for specific high-risk racial/ethnic minority subpopulations
of migrant workers, transgender individuals, or youth in non-school
settings, including LGBTQ youth, must be culturally and linguistically
appropriate. Fidelity of all interventions and public health strategies
must be maintained by adhering to their specific core elements. This
includes adapting and tailoring all training curricula and written
materials on each intervention selected, development of a national
marketing and diffusion plan for the adapted and tailored
interventions, and the provision of CBA to implement adapted and
tailored interventions.
This program addresses the ``Healthy People 2010'' focus area of
HIV. This program also addresses the goals stated in CDC's HIV
Prevention Strategic Plan through 2005, which can be found at https://
www.cdc.gov/hiv/partners/psp.htm; and Advancing HIV Prevention: New
Strategies for a Changing Epidemic at https://www.cdc.gov/hiv/partners/
ahp.htm.
Measurable outcomes of the program will be in alignment with one
(or more) of the following performance goals for the National Center
for HIV, STD and TB Prevention (NCHSTP):
1. Decrease the number of persons at high risk for acquiring or
transmitting HIV infection.
2. By 2010, increase by 13 percent the proportion of HIV-infected
people who know they are infected, as measured by the proportion
diagnosed before progression to AIDS (Baseline: 76 percent in 2000;
Target for 2010: 85 percent).
3. By 2010, increase to at least 80 percent the proportion of HIV-
infected people who are linked to appropriate prevention, care, and
treatment services, as measured by those who report having received
some form of medical care within three months of their HIV diagnosis
(2001 Baseline: 79 percent).
4. Strengthen the capacity to develop and implement effective HIV
prevention interventions.
CBA developed under this program will be categorized as
Strengthening Interventions for HIV Prevention (designated as Focus
Area [FA] 2) in the CBA model, as referenced in Attachment I.
Program Goals: The goal for this program is to strengthen
interventions for HIV prevention by improving the capacity of CBOs and
health departments to implement, improve, and evaluate HIV prevention
interventions specifically targeting high-risk racial/ethnic minority
subpopulations. The minority subpopulations are migrant workers,
transgender individuals, and youth in non-school settings, including
lesbian/gay/bisexual/transgender and questioning (LGBTQ) youth.
This announcement is only for non-research activities supported by
CDC. If research is proposed, the application will not be reviewed. For
the definition of research, please see the CDC website at the following
Internet address: https://www.cdc.gov.od/ads/opspoll1.htm.
Activities: Awardee activities for this program are as follows: All
applicants are required to implement awardee activities by developing
process objectives and activities for the following:
1. Provide ongoing individualized CBA to CDC's directly funded
CBOs, health departments, and health department-funded CBOs in the
adaptation, implementation, quality assurance, and evaluation of
effective science-based behavioral HIV prevention interventions for
high-risk, racial/ethnic minority subpopulations of migrant workers,
transgender individuals, or youth in non-school settings, including
LGBTQ youth. CBA providers will utilize CDC's draft adaptation guidance
to: (a) Conduct assessments of needs and community resources; (b)
identify and address gaps in CBA services; (c) collaborate with other
sources of CBA (including other CDC CBA providers and CBOs specifically
receiving CDC's Program Announcement 04064 ADAPT supplemental for
adapting and tailoring DEBI interventions); (d) notify, collaborate and
coordinate with state and local health departments in the delivery of
CBA services within their health jurisdictions; and (e) leverage other
federal, state or local resources.
Examples of prevention interventions are health education and risk
reduction; outreach capacity and preparation for testing; HIV testing;
referrals; prevention and partner counseling; prevention case
management; interventions to prevent perinatal transmission; and rapid
testing in non-traditional settings, such as correctional facilities
and high-risk community venues.
2. Provide CBA to health departments and their funded CBOs on
culturally appropriate HIV prevention interventions and strategies for
high-risk racial/ethnic minority subpopulations of migrant workers,
transgender individuals, or youth in non-school settings, including
LGBTQ youth. This includes: (a) Obtaining and utilizing
[[Page 19084]]
input from high-risk, racial/ethnic minority subpopulations of migrant
workers, transgender individuals, or youth in non-school settings,
including LGBTQ youth proposed for this project; and (b) incorporating
cultural competency and linguistic and educational appropriateness into
all CBA activities.
CBA for HIV prevention may include methods for practicing
abstinence, monogamy (i.e., being faithful to a single sexual partner),
or safer sex (i.e., using condoms consistently and correctly). These
approaches can avoid risk or effectively reduce risk for HIV infection.
Prevention interventions should also include risk reduction and
avoidance for co-infections with other sexually transmitted diseases,
blood-borne diseases (i.e., Hepatitis B and C), and tuberculosis.
3. Work with CDC program consultants and Science Application Team
technical monitors, who are responsible for ensuring fidelity,
consistency, and support for the delivery of evidence-based HIV
prevention interventions and strategies. With their help, develop
collaborative partnerships with the originators of the supported
science-based interventions, other social and behavioral scientists,
and public health experts to adapt and tailor a minimum of two (2)
science-based behavioral interventions for high-risk, racial/ethnic
minority subpopulations of migrant workers, transgender individuals, or
youth in non-school settings, including LGBTQ youth. These partners
will be responsible for reviewing all materials produced to ensure
fidelity to the original intervention and for collaborating on the
delivery of CBA. This includes: (a) Development of adaptation and
tailoring materials based on CDC's draft adaptation guidance on each
intervention; (b) provision of CBA, including training and TA, on
adapting and tailoring science-based behavioral HIV prevention
interventions; and (c) development of a national marketing and
diffusion plan for the interventions in the CDC's Procedural Guidance
and other CDC-supported strategies for specific high-risk, racial/
ethnic minority subpopulations. Note: Specifically for DEBI
interventions, all materials related to the adaptation and tailoring of
the interventions will need to be reviewed by CDC program consultants,
Science Application Team technical monitors, and original
investigators, as appropriate.
4. Collaborate with CDC, CDC-funded CBA and TA providers, and
locally based partners and contractors to plan and deliver CBA that is
consistent with the requirements of the DEBI interventions and CDC
program requirements (as provided in trainings for grantees) and avoids
duplication of services. This includes developing training materials,
diffusing best program practices and interventions for HIV-negative and
HIV-positive persons, and supporting partners with orientation and
training to help them deliver effective and efficient services. Note:
To achieve cost-effectiveness, other partners and experts contracted by
CBA providers should be locally based and culturally competent.
5. Core Performance Indicators. To ensure quality programs and to
measure progress, all applicants receiving funding are required to
report on the following core performance indicators:
(a) Number of CDC-funded CBOs that serve high-risk, racial/ethnic
minority subpopulations of migrant workers, transgender individuals, or
youth in non-school settings, including LGBTQ youth, receiving CBA on
adapted and tailored science-based behavioral prevention interventions
and public health strategies that increase behaviors that reduce risk
for transmission or acquisition of HIV.
(b) Number of health department-funded CBOs that serve high-risk,
racial/ethnic minority subpopulations of migrant workers, transgender
individuals, or youth in non-school settings, including LGBTQ youth,
receiving CBA on adapted and tailored science-based behavioral
prevention interventions and public health strategies that increase
behaviors that reduce risk for transmission or acquisition of HIV.
(c) Number of CDC-funded CBOs that report agreement with timeliness
in completion of CBA services.
(d) Number of health department-funded CBOs that report agreement
with timeliness in completion of CBA services.
(e) Number of CDC-funded CBOs that receive CBA and, in turn,
deliver adapted and tailored interventions and/or public health
strategies to high-risk, racial/ethnic minority subpopulations of
migrant workers, transgender individuals, or youth in non-school
settings, including LGBTQ youth.
(f) Number of health department-funded CBOs that receive CBA and,
in turn, deliver adapted and tailored interventions and/or public
health strategies to high-risk, racial/ethnic minority subpopulations
of migrant workers, transgender individuals, or youth in non-school
settings, including LGBTQ youth.
(g) Number of CDC-funded CBOs, health department-funded CBOs, and
other stakeholders serving high-risk, racial/ethnic minority
subpopulations of migrant workers, transgender individuals, or youth in
non-school settings, including LGBTQ youth, receiving CBA on
implementing realistic and feasible evaluation efforts of adapted and
tailored science-based behavioral prevention interventions.
Applicants will be responsible for the following in response to the
performance indicators:
(1) Set baseline, one-year, and four-year target goals (target
goals will be negotiated with CDC post-award).
(2) Use performance indicators for the design of a monitoring
evaluation plan.
(3) Collect process and outcome monitoring data and report to the
CDC.
Applicants, with the substantial involvement of CDC, will be
accountable for achieving performance target goals. If an applicant
fails to achieve its target, CDC will work with the applicant to
determine what steps can be taken to improve performance. CDC
involvement may include TA, conditional or restrictive funding. If
applicant's performance fails to improve, CDC in accordance with
applicable federal regulations may take enforcement actions such as,
suspension or termination of the Notice of Award (NoA).
6. Implement an evaluation-monitoring plan based on logic modeling
that links outcomes (both short- and long-term) with program
activities/processes and the theoretical assumptions/principles of the
program performance indicators.
The plan should outline the process and outcome data to be
collected, identify sources of information, explain the methods by
which information will be collected, and outline the process for
analyzing and interpreting information, and using findings for program
improvement.
7. Identify the CBA training needs of your own program and staff.
Develop and implement a plan to address these needs.
8. Develop protocols that respond to new CBA requests, including
submission of notification and completion of forms. Refer all CBA
requests outside your scope of work to the CDC CBA coordinator
responsible for tracking and assigning CBA requests, following
procedures to be provided by CDC.
9. Participate in CDC-coordinated CBA networks to enhance
communication, coordination, cooperation, and training.
[[Page 19085]]
10. Implement a quality assurance strategy that ensures the
delivery of high-quality services.
11. Develop and implement an effective strategy for marketing your
CBA services.
12. Report planned group CBA events to the Capacity Building Branch
(CBB) Training Calendar, as provided by CDC, for dissemination to HIV
prevention partners and constituents.
13. Facilitate the dissemination of information about successful
CBA strategies and ``lessons learned'' through peer-to-peer
interactions, meetings, workshops, conference presentations, case
studies, and communications with CDC program consultants.
14. Take the Adaptation and Tailoring course provided by the STD/
HIV Prevention Training Centers (PTC); follow the adaptation and
tailoring guidance document, once it is developed by CDC, and
collaborate with CDC behavioral and social scientists in developing
adapted and tailored materials for the behavioral interventions.
15. Coordinate with local and state health departments prior to
providing CBA services.
16. Attend all post-award training events.
17. Submit materials developed with funding through this program
announcement to the CDC National Prevention Information Network (NPIN)
for access by the public free of charge and dissemination by NPIN.
18. Check with the CDC NPIN to determine if suitable materials are
already available. For further information on NPIN services and
resources, contact NPIN at 1-800-458-5231; visit its website at
www.cdcnpin.org; or send requests by fax to 1-888-282-7681 (TTY users:
1-800-243-7012).
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC activities for this program are as follows:
1. Support all funded awardees by coordinating national networks of
capacity building providers.
2. Provide consultation and TA in designing, planning, developing,
operating, and evaluating activities (such as progress reporting,
submitting information for the training calendar, etc.) based on CDC's
standards and CDC program requirements. CDC may provide consultation
and TA both directly from CDC and indirectly through prevention
partners, such as health departments, national and regional minority
partners, CBA partners, trainers, contractors, and other national
organizations.
3. Monitor the performance of program and fiscal activities through
progress reports, data reporting, site visits, conference calls, and
ensuring compliance with federally mandated requirements, such as use
of a materials review panel and internal audit procedures.
4. Add or refine performance indicators over the course of the
project period. (For additional information on performance indicators,
see Application and Submission Information thru NPIN.)
5. Provide up-to-date scientific information and training on the
risk factors for transmitting HIV infection among persons living with
HIV/AIDS; HIV prevention services for individual and partner
counseling, HIV testing, and referral to care and treatment; and proven
effective behavioral interventions for people at risk for transmitting
HIV or becoming infected.
6. Provide up-to-date information and training on CDC's draft
adaptation guidance developed by CDC with input from internal and
external researchers, HIV prevention intervention implementers and
community advocates.
7. Assist in the development of collaborative efforts with state
and local health departments, HIV prevention community planning groups,
CBOs that receive direct funding from CDC, and other federally
supported organizations providing HIV/AIDS services.
8. Facilitate the exchange of information about successful
interventions, program models, and ``lessons learned'' through grantee
meetings, workshops, conferences, newsletters, the Internet, and
communications with CDC project officers. CDC will also facilitate the
exchange of program information and TA among community-based
organizations, health departments, and national and regional
organizations.
9. Ensure that any products developed with these funds reflect both
cultural competence and sound evidence-based science. These products
must first be reviewed and cleared by the original behavioral
scientist(s) for the selected DEBI intervention(s) before submitting
them to CDC for clearance.
10. Conduct an overall evaluation of the project.
11. Disseminate CBA Training Calendar of training activities.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2005.
Approximate Total Funding: $2,876,000 (This amount is an estimate
and is subject to availability of funds.).
Approximate Number of Awards: Six (6).
Approximate Average Award: $440,000 (This amount is for the first
12-month budget period and includes both direct and indirect costs.).
Floor of Award Range: $400,000.
Ceiling of Award Range: $500,000 (This ceiling is for the first 12-
month budget period.).
Anticipated Award Date: August 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Four (4) years.
Throughout the project period, CDC's commitment to the continuation
of awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations, such as:
Public nonprofit organizations.
Private nonprofit organizations.
Universities.
Colleges.
Community-based organizations.
Faith-based organizations.
Federally recognized Indian tribal government.
Indian tribal organizations.
III.2. Cost-Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
Special Requirements: If your application is incomplete or non-
responsive to the special requirements listed in this section, it will
not be entered into the review process. You will be notified that your
application did not meet submission requirements.
Applicants must provide proof of eligibility as outlined
in Section IV.2. of this announcement.
[[Page 19086]]
All applicants will be required to provide CBA within the
United States and its Territories.
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
Governmental, municipal agencies or affiliates of
governmental or municipal agencies (e.g., health departments, school
boards, public hospitals) are not eligible to apply.
Organizations currently receiving more than one award for
capacity building assistance from CDC's Capacity Building Branch are
not eligible to apply.
A minimum of two interventions or CDC-supported
strategies, listed in the ``Purpose'' section, must be adapted and
tailored for high-risk, racial/ethnic minority subpopulations of
migrant workers, transgender individuals, or youth in non-school
settings, including LGBTQ youth. For additional information about
interventions and CDC-supported strategies, please visit: https://
www.cdc.gov/hiv/partners/pa04064_cbo.htm and https://www.cdc.gov/hiv/
pubs/hivcompendium/HIVcompendium.htm.
Preference will be given to organizations that provide
evidence of having previously adapted and tailored interventions listed
under the ``Purpose'' section for migrant workers, transgender
individuals, or youth in non-school settings, including LGBTQ youth.
CDC may allocate additional funding to this program
announcement to provide CBA as described in this announcement to reach
organizations specifically targeting underserved Latino/a youth at risk
for HIV and STDs (i.e., high-risk runaway Latino/a youth engaging in
survival activities such as sex in exchange for drugs, money, shelter,
or food).
Note: Title 2 of the United States Code Section 1611 states that
an organization described in Section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity, use application form PHS
5161-1.
CDC strongly encourages you to submit your application
electronically by utilizing the forms and instructions posted for this
announcement at www.grants.gov.
Application forms and instructions are available on the CDC
website, at the following Internet address: www.cdc.gov/od/pgo/
forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms online, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
To request an application kit (which includes the request for
application, required forms, supplemental information, CBA Guidelines,
and other information), contact CDC's National Prevention Information
Network (NPIN) at 1-800-458-5231; visit its website at https://
www.cdcnpin.org; or send requests by fax to 1-888-282-7681 (TTY users:
1-800-243-7012). This announcement and associated forms can also be
found on the CDC Internet home page, https://www.cdc.gov. Click on
Funding Opportunities then Grants and Cooperative Agreements.
IV.2. Content and Form of Submission
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 40 pages (excluding budget,
appendices and attachments). If your narrative exceeds the page limit,
only the first pages which are within the page limit will be reviewed.
Font size: 12 point unreduced.
All material must be typewritten; single-spaced.
Paper size: 8.5 x 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
Program announcement title and number must appear on each
page of the application.
Number each page sequentially, including appendices and
attachments, and provide a complete table of contents to the
application, its appendices and attachments.
Narrative. Your narrative should address activities to be conducted
over the entire project period, and must include the following items in
the order listed:
1. Abstract
Please provide a brief four-page summary of the proposed program
activities, including the following information:
a. A description of the high-risk subpopulation of migrant workers,
transgender individuals, or youth in non-school settings, including
LGBTQ youth, for whom you propose to adapt and tailor interventions or
CDC-supported strategies.
b. A description of all the science-based behavioral interventions
or CDC-supported strategies you propose to adapt and tailor.
c. A description of your strategy that includes: (1) All
interventions previously adapted; (2) the proposed overall marketing
and diffusion plan; (3) the overall evaluation plan; and (4) the
proposed plan to deliver CBA nationally.
d. A description of your organization's three-year record of
experience providing CBA to consumers that serve a major racial/ethnic
minority population listed above or of providing direct HIV prevention
services to a major racial/ethnic minority population.
2. Program Plan
The program plan should include the following:
a. Proposed Plan
A description of your proposed plan for building capacity for
adapting, tailoring and implementing interventions listed in the
``Purpose'' section of this announcement. In addition, include a
description of the HIV prevention interventions you have previously
adapted and tailored, including training and TA delivered. Include
epidemiological evidence and other quantitative and qualitative data to
support your proposed program plan.
b. Objectives
What are your proposed specific, measurable, appropriate, realistic
and time-phased (SMART) objectives to address the awardee activities?
c. Activities
List and describe the proposed activities that relate to each of
the objectives listed above.
d. Timeline
Provide a time line and list staff responsible for accomplishing
and implementing activities in the first year.
3. Program Experience
a. Describe your organization's program experience as it relates to
providing CBA nationally, including training and TA on adapting,
tailoring, marketing and evaluating science-based behavioral HIV
prevention interventions.
b. Describe the methods and recipients of CBA services previously
provided by your organization.
[[Page 19087]]
c. Describe your organization's program experience collaborating
with behavioral science researchers as well as other HIV prevention
agencies, including state and local health departments.
d. Describe your organization's program experience in providing CBA
that responds effectively to the cultural, gender, environmental,
social, and linguistic characteristics of your proposed high-risk
subpopulation of migrant workers, transgender individuals, or youth in
non-school settings, including LGBTQ youth. In answering this question,
describe the types of services provided and list any culturally,
linguistically, and developmentally appropriate curricula and materials
that your organization has adapted or developed.
4. Organizational Capacity
a. Indicate where the proposed program will be located within the
organization (e.g., within the Office of the Executive Director, the
Health Services Department, the HIV Prevention Section/Department,
etc.).
b. Describe your fiscal management system and how it functions.
c. Describe your human resource management system and how it
functions.
d. Describe your Management Information System (MIS), including
functional role and software assets.
e. Summarize how the systems and assets described above will be
used to support and manage the proposed program.
f. Provide the number of your full-time employees (FTEs) and
describe their expertise related to social/behavioral science,
curriculum development, training, marketing, and evaluation.
5. Evaluation Monitoring Plan
a. Provide baseline, one-year interim and four-year overall target
performance goals based on the core performance indicators.
b. Describe the process and outcome data you will collect. Note:
Data collected must relate to your objectives and the performance
indicators.
c. Describe the methods for collecting, analyzing, interpreting,
and reporting your process and outcome data.
d. Describe the plans for using your process and outcome data to
improve the program.
6. Budget and Staffing Breakdown and Justification (Not Included in
Narrative Page Limit)
a. Provide a detailed budget for each proposed activity. Justify
all operating expenses in relation to the planned objectives and
related activities. CDC may not approve or fund all proposed
activities. Be precise about the justification for each budget item and
itemize calculations wherever appropriate.
b. For each contract and consultant contained within the
application budget, describe the type(s) of organizations or parties to
be selected and the method of selection; identify the specific
contractor(s), if known; and describe the expertise related to
behavioral science, curriculum development, training, marketing, and
evaluation. Describe services to be performed, and justify the use of a
third party to perform these services; provide a breakdown of and
justification for the estimated costs of the contractors and
consultants; specify the period of performance; and describe the
methods to be used for contract monitoring.
c. Provide a job description for each position, specifying job
title, function, general duties, activities and expertise related to
behavioral science, curriculum development, training, marketing, and
evaluation. Also provide salary range or rate of pay, and the level of
effort and percentage of time, to be spent on activities that would be
funded through this cooperative agreement. If the identity of any key
personnel who will fill a position is known, his/her name and resume
should be included in the appendix section. Experience and training
related to the proposed project should be noted. If the identity of
staff is not known, describe your recruitment plan. If volunteers are
involved in the project, provide their job descriptions and expertise
related to behavioral science, curriculum development, training,
marketing, and evaluation.
7. Proof of Eligibility
Applicants must complete the following section on proof of
eligibility, including providing the following documents as
appropriate. Include eligibility documentation as ``Attachment A.''
Applications without the required documentation will be considered
non-responsive.
CBA developed under this program announcement will be
delivered to CBA consumers serving one or more of the four major
racial/ethnic populations as follows:
Black/African American
Hispanic/Latino
Asian/Pacific Islander
American Indian/Alaska Native
Documentation that your organization has the specific
charge from its executive board or governing body to operate nationally
within the United States and its Territories. Documentation should
include a copy of the statement from your organization's Articles of
Incorporation, Bylaws, or Board Resolution.
A copy of the current, valid Internal Revenue Service
(IRS) determination letter of your organization's 501(c)3 tax-exempt
status.
Evidence that your organization has been in operation for
three years as documented by annual agency reports, a board resolution,
or other documentation.
Evidence that your organization has a three-year record of
experience, as documented by annual agency reports, a board resolution,
or other documentation, in the following:
1. Providing CBA to CBOs and health departments on adapting,
tailoring and implementing science-based behavioral HIV prevention
interventions for high-risk, racial/ethnic minority subpopulations of
migrant workers, transgender individuals, or youth in non-school
settings including LGBTQ youth for which you are applying.
2. Providing CBA to CBOs and health departments that serve a major
racial/ethnic minority population(s) listed above, or providing direct
HIV prevention services to a major racial/ethnic minority population.
In order to enhance program efficacy and facilitate learning,
applicants must demonstrate cultural competence, including access to
and credibility with the targeted populations mentioned above.
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes curriculum vitaes,
resumes, organizational charts, letters of support, etc.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access https://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC website at: https://www.cdc.gov/
od/pgo/funding/pubcommt.htm. If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
[[Page 19088]]
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
Application Deadline Date: May 27, 2005.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date.
You may submit your application electronically at www.grants.gov.
Applications completed online through Grants.gov are considered
formally submitted when the applicant organization's Authorizing
Official electronically submits the application to www.grants.gov.
Electronic applications will be considered as having met the deadline
if the application has been submitted electronically by the applicant
organization's Authorizing Official to Grants.gov on or before the
deadline date and time.
If you submit your application electronically with Grants.gov, your
application will be electronically time/date stamped, which will serve
as receipt of submission. You will receive an e-mail notice of receipt
when CDC receives the application.
If you submit your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery by the closing date and time. If CDC
receives your submission after closing due to: (1) Carrier error, when
the carrier accepted the package with a guarantee for delivery by the
closing date and time, or (2) significant weather delays or natural
disasters, you will be given the opportunity to submit documentation of
the carrier's guarantee. If the documentation verifies a carrier
problem, CDC will consider the submission as having been received by
the deadline.
If you submit a hard copy application, CDC will not notify you upon
receipt of your submission. If you have a question about the receipt of
your application, first contact your courier. If you still have a
question, contact the PGO-TIM staff at: 770-488-2700. Before calling,
please wait two to three days after the submission deadline. This will
allow time for submissions to be processed and logged.
This announcement is the definitive guide on application content,
submission address, and deadline. It supersedes information provided in
the application instructions. If your submission does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that you did not meet the submission
requirements.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for state and local governmental review of proposed federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospective
applications and to receive instructions on your state's process. Click
on the following link to get the current SPOC list: https://
www.whitehouse.gov/omb/grants/spoc.html.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may not be used for research.
Reimbursement of pre-award costs is not allowed.
Funds available under this announcement must:
a. Support CBA that improves the capacity of the CBOs to implement,
improve, and sustain programs that support the delivery of effective
HIV prevention services for high-risk, racial/ethnic minority sub-
populations.
b. Support CBA that gives priority to CBOs directly funded by CDC,
followed by CBOs funded by state and local health departments.
c. Not supplant or duplicate existing funding.
d. Not be used to provide direct provision of health education and
risk reduction and avoidance (HERR) services or patient care, including
substance abuse treatment, medical treatment, or medications.
e. Not be used to support the cost of developing applications for
other federal funds.
Organizations receiving award must directly provide the
majority of CBA services by their employed staff.
Note: All work provided by subcontractors is subject to approval
and the applicant may not receive an award if proposed
subcontractors are providing the majority of CBA services.
Funding estimates and project period may change based on the
availability of funds, scope of work, and quality of the applications
received, appropriateness and reasonableness of the budget
justifications, and proposed use of project funds.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement must be less than 12
months of age.
Guidance for completing your budget can be found on the CDC
website, at the following Internet address: https://www.cdc.gov/od/pgo/
funding/budgetguide.htm.
IV.6. Other Submission Requirements
Application Submission Address: CDC strongly encourages applicants
to submit electronically at: www.grants.gov. You will be able to
download a copy of the application package from www.grants.gov,
complete it offline, and then upload and submit the application via the
Grants.gov site. E-mail submission will not be accepted. If you are
having technical difficulties in Grants.gov, they can be reached by e-
mail at www.support@grants.gov">www.support@grants.gov or by phone at 1-800-518-4726 (1-800-
GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m.
Eastern Time, Monday through Friday.
CDC recommends that you submit your application to Grants.gov early
enough to resolve any unanticipated difficulties prior to the deadline.
You may also submit a back-up paper submission of your application. Any
such paper submission must be received in accordance with the
requirements for timely submission detailed in Section IV.3. of the
grant announcement. The paper submission must be clearly marked:
``BACK-UP FOR ELECTRONIC SUBMISSION.''
The paper submission must conform to all requirements for non-
electronic submissions. If both electronic and back-up paper
submissions are received by the deadline, the electronic version will
be considered the official submission.
It is strongly recommended that you submit your grant application
using Microsoft Office products (e.g., Microsoft Office, Microsoft
Excel, etc.). If you do not have access to Microsoft Office products,
you may submit a PDF file. Directions for creating PDF files can be
found on the Grants.gov web site. Use of file formats other than
Microsoft Office or PDF may result in your file being unreadable by our
staff.
OR
Submit the original and two hard copies of your application by mail
or express delivery service to: Technical Information Management--
RFA 05051, CDC Procurement and Grants Office,
[[Page 19089]]
2920 Brandywine Road, Atlanta, GA 30341.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Program Plan (40 Points)
a. Is the program based on high-prevalence epidemiological evidence
and other concrete quantitative and qualitative data? (10 points)
b. Are the proposed program objectives specific, measurable,
appropriate, realistic, and time-phased? (10 points)
c. What is the likelihood that the proposed program activities will
accomplish the proposed program objectives? (10 points)
d. Is the timeline feasible? (10 points)
2. Program Experience (20 Points)
Is the applicant's program experience relevant to adapting and
tailoring science-based behavioral HIV prevention interventions,
curriculum development, training and TA, marketing, and evaluation for
high-risk racial/ethnic minority subpopulations of migrant workers,
transgender individuals, or youth in non-school settings including
LGBTQ youth?
3. Organizational Capacity (20 Points)
Does the applicant demonstrate current organizational capacity to
adapt, tailor, implement, and evaluate HIV interventions for high-risk
racial/ethnic minority subpopulations of migrant workers, transgender
individuals, or youth in non-school settings including LGBTQ youth?
4. Evaluation-Monitoring Plan (20 Points)
Is the evaluation-monitoring plan feasible and does it address the
required performance indicators, process and outcome data collection,
analysis, and reporting activities?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by National
Center for HIV, STD and TB Prevention (NCHSTP)/Division of HIV and AIDS
Prevention (DHAP)/Capacity Building Branch (CBB). Incomplete
applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
A Special Emphasis Review Panel consisting of external experts will
evaluate complete and responsive applications according to the criteria
listed in the ``V.1. Criteria'' section above.
In addition, the following factors may affect the funding decision:
1. CDC's commitment to ensure overall funding for CBA services that
serve each of the four major racial/ethnic minority populations.
2. CDC's commitment to ensure overall funding for CBA services,
which is distributed in proportion to the HIV/AIDS disease burden among
high-risk racial/ethnic minority sub-populations.
3. CDC's commitment to ensure that CBA funding will include
different high-risk racial/ethnic minority subpopulations of migrant
workers, transgender individuals, or youth in non-school settings
including LGBTQ youth.
4. Preference will be given to organizations that provide evidence
of having previously adapted and tailored interventions listed under
the ``Purpose'' section for migrant workers, transgender individuals,
or youth in non-school settings, including LGBTQ youth.
5. CDC may allocate additional funding to this program announcement
to provide CBA as described in this announcement to reach organizations
specifically targeting underserved Latino/a youth at risk for HIV and
STDs (i.e., high-risk runaway Latino/a youth engaging in survival
activities such as sex in exchange for drugs, money, shelter, or food).
CDC will provide justification for any decision to fund out of rank
order.
V.3. Anticipated Announcement and Award Dates
Anticipated Award Date: August 1, 2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the
CDC Procurement and Grants Office. The NoA shall be the only binding,
authorizing document between the recipient and CDC. The NoA will be
signed by an authorized Grants Management Officer and mailed to the
recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Parts 74 and 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372 Review
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
AR-20 Conference Support
AR-21 Small, Minority, and Women-Owned Business
AR-23 States and Faith-Based Organizations
AR-25 Release and Sharing of Data
Additional information on these requirements can be found on the
CDC website at the following Internet address: https://www.cdc.gov/od/
pgo/funding/ARs.htm.
An additional Certifications form from the PHS 5161-1 application
needs to be included in your Grants.gov electronic submission only.
Refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1Certificates.pdf.
Once the form is filled out, attach it to your Grants.gov submission as
Other Attachment Forms.
VI.3. Reporting Requirements
You must provide CDC with an original plus two hard copies of the
following reports:
1. First trimester progress report, due 30 days after the first
four (4) months of the project period. The report must contain the
following elements:
a. Current Budget Period Activities Objectives.
[[Page 19090]]
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of effectiveness.
f. Additional requested information, including (1) data related to
performance target goals; (2) data on progress toward achieving
objectives; (3) an inventory of total individual capacity building
assistance and proactive training for the reporting period; and (4)
data related to the quality assurance system.
2. Second trimester interim progress report shall be due 30 days
after the completion of the first eight (8) months of the project
period. This second trimester progress report will serve as your non-
competing continuation application for the next funding cycle. (See
Continuing Application Requirements provided by Procurement and Grants
Office.) This report must include elements a-f, as listed in the first
trimester report, and be completed during this time period (months 5-
8). The report should also include the following:
a. Base line and actual level of core performance indicators.
b. Specific guidance, which will be provided by the CDC three
months prior to the due date.
3. The third trimester progress report shall be due 30 days after
the end of the budget period. This report must include elements a-f as
listed in the first trimester report, elements a-b as listed in the
second trimester report, and completed during this time period (months
9-12).
4. Financial status report is due no more than 90 days after the
end of the budget period.
5. Final financial and performance reports are due no more than 90
days after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement.
For Pre-application Technical Consultation: Send questions
regarding this application to DHAPCBAPT@CDC.GOV. You will receive a
response within 24-48 hours.
For general questions, contact: Technical Information Management
Section, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341. Telephone: 770-488-2700.
For program technical assistance, contact: Gerlinda Gallegos
Somerville, Public Health Analyst, Centers for Disease Control and
Prevention, National Center for HIV, STD, and TB Prevention, Division
of HIV/AIDS Prevention, Capacity Building Branch, 1600 Clifton Road,
Mailstop E-40, Atlanta, GA 30333, Telephone: 404-639-2918. E-mail
address: DHAPCBAPT@CDC.GOV.
For financial, grants management, or budget assistance, contact:
Roslyn Curington, Grants Management Specialist, Centers for Disease
Control and Prevention, Procurement and Grants Office, 2920 Brandywine
Road, Room 3000, Atlanta, Georgia 30341-4146. Telephone: 770-488-2767,
E-mail address: zlp8@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: April 6, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-7286 Filed 4-11-05; 8:45 am]
BILLING CODE 4163-18-P